» Authors » Michael Duerr

Michael Duerr

Explore the profile of Michael Duerr including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 326
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vrellaku B, Sethw Hassan I, Howitt R, Webster C, Harriss E, McBlane F, et al.
Mol Ther . 2024 Jul; 32(10):3220-3259. PMID: 39044426
The emergence of adeno-associated virus (AAV)-based gene therapy has brought hope to patients with severe monogenic disorders. However, immune responses to AAV vectors and transgene products present challenges that require...
2.
Grothgar E, Goerlich N, Samans B, Skopnik C, Metzke D, Klocke J, et al.
Front Med (Lausanne) . 2022 Aug; 9:928516. PMID: 35911418
Early detection of kidney transplant (KT) rejection remains a challenge in patient care. Non-invasive biomarkers hold high potential to detect rejection, adjust immunosuppression, and monitor KT patients. So far, no...
3.
Bachmann F, Budde K, Suttorp N, Lingscheid T, Stegemann M, Osmanodja B, et al.
Transpl Int . 2022 Apr; 35:10109. PMID: 35431640
Antiviral drugs have shown little impact in patient infected with acute respiratory coronavirus 2 (SARS-CoV-2). Especially for immunocompromised persons positive for SARS-CoV-2, novel treatments are warranted. Recently, the U.S. FDA...
4.
Mang J, Hennig L, Liefeldt L, Duerr M, Lehner L, Bichmann A, et al.
Res Rep Urol . 2021 Jul; 13:495-499. PMID: 34285889
Purpose: Focal segmental glomerulosclerosis (FSGS) is a common cause for end-stage renal disease that can recur in the graft after kidney transplantation. The incidence of FSGS recurrence is reported in...
5.
Zhang Q, Budde K, Schmidt D, Halleck F, Duerr M, Naik M, et al.
Front Med (Lausanne) . 2021 Jul; 8:666319. PMID: 34277656
Transplant glomerulopathy (TG) is one of the main causes of post-transplant proteinuria (PU). The features and possible risk factors for proteinuria in TG patients are uncertain. We investigated all patients...
6.
Mayrdorfer M, Liefeldt L, Wu K, Rudolph B, Zhang Q, Friedersdorff F, et al.
J Am Soc Nephrol . 2021 Apr; 32(6):1513-1526. PMID: 33883251
Background: Few studies have thoroughly investigated the causes of kidney graft loss (GL), despite its importance. Methods: A novel approach assigns each persistent and relevant decline in renal function over...
7.
Doberer K, Duerr M, Halloran P, Eskandary F, Budde K, Regele H, et al.
J Am Soc Nephrol . 2021 Jan; 32(3):708-722. PMID: 33443079
Background: Late antibody-mediated rejection (ABMR) is a leading cause of transplant failure. Blocking IL-6 has been proposed as a promising therapeutic strategy. Methods: We performed a phase 2 randomized pilot...
8.
Duerr M, Liefeldt L, Friedersdorff F, Choi M, Ollinger R, Hofmann J, et al.
J Clin Med . 2021 Jan; 10(1). PMID: 33383877
Transplant candidates are facing incremental mortality risks on the waiting list. Here, we report a novel strategy to expand the donor pool by including hepatitis C seropositive (HCV+) donors. We...
9.
Zhang Q, Rudolph B, Choi M, Bachmann F, Schmidt D, Duerr M, et al.
Transpl Int . 2020 Nov; 34(2):259-271. PMID: 33205460
Proteinuria and transplant glomerulopathy (TG) are common in kidney transplantation. To date, there is limited knowledge regarding proteinuria in different types of TG and its relationship to allograft survival. A...
10.
Choi M, Bachmann F, Naik M, Duettmann W, Duerr M, Zukunft B, et al.
J Clin Med . 2020 Oct; 9(11). PMID: 33114149
The coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 denotes a global health issue. Data regarding COVID-19 incidence in kidney transplant recipients (KTR) are sparse. From 19 March to 19...